NCT05885269View on ClinicalTrials.gov

Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Alopecia Areata
Interventions
DRUG

Group A applied topical Clobetasol Propionate

Patient in group-A applied clobetasol propionate 0.05% twice daily for upto 03 months

DRUG

Group B applied topical Tacrolimus

Group-B applied topical tacrolimus 0.1% twice daily for upto 3 months.

Trial Locations (1)

Unknown

Danyal Sajjad, Abbottabad

All Listed Sponsors
lead

Combined Military Hospital Abbottabad

OTHER